文献速递药物不良反应与药物警戒

揭示抗胆碱能负担量表的局限:法国药物警戒数据库不良反应研究

Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database.
PubMed 文献 · Drug Saf · 2026-01-13

本研究基于法国国家药物警戒数据库(FPVD,1985-2024)提取疑似药物具有高抗胆碱能评分或同类的病例,描述抗胆碱能不良反应(ADR)及涉及药物。在101365例报告中,9629例(9.5%)涉及至少一种目标ADR,意识模糊最常见且81%为严重,部分引发ADR的药物未被常用量表收录或评分偏低。

要点

  • 抗胆碱能ADR可发生于各年龄段,中位年龄61岁,女性占58%。
  • 意识模糊最常见(4603例,81%严重),肠梗阻98%为严重。
  • 部分引发ADR的药物未被常用量表收录或评分偏低。

核心结论

  • 现有抗胆碱能负担量表可能未完全覆盖真实世界中与抗胆碱能相关事件有关的药物范围。

研究设计与样本

  • 基于法国国家药物警戒数据库(FPVD,1985-2024)的回顾性研究,纳入疑似药物具有高抗胆碱能评分(依据22种量表之一)或属于同类药物的病例。

主要发现

  • 在101365例报告中,9629例(9.5%)涉及至少一种目标抗胆碱能ADR。
  • 发生至少一种抗胆碱能ADR的患者中位年龄61岁(四分位距38-79),女性占58%。
  • 意识模糊报告最多(4603例,其中81%为严重),其次为心动过速(1541例,70%严重)和尿潴留(1061例,75%严重)。
  • 561例肠梗阻报告中98%为严重。
  • 报告数最多的药物类别为抗焦虑药、抗抑郁药和抗精神病药。

关键数值与推荐

  • 抗胆碱能ADR包括意识模糊、青光眼、心动过速、尿潴留、便秘、肠梗阻和瞳孔散大。
  • 部分与ADR相关的药物在常用量表(如抗胆碱能认知负担量表)中未收录或评分较低。

临床怎么用

  • 临床应关注抗胆碱能ADR,尤其意识模糊、心动过速、尿潴留和肠梗阻,并注意常用量表可能低估某些药物的抗胆碱能负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: The anticholinergic burden is the cumulative effect of drugs with anticholinergic properties and is typically measured using one of several anticholinergic scales. We hypothesised that these scales may not fully capture all the relevant adverse drug reactions (ADRs). By accessing the French national pharmacovigilance database (FPVD) and focusing on drug classes known to induce anticholinergic ADRs, the objectives of the present study were to describe the reported ADRs, characterise the drugs involved, and examine the drugs' classification within anticholinergic scales. METHODS: Cases were extracted from the FPVD (1985-2024) when the suspected drug (i) had a high anticholinergic score, according to one or more of 22 anticholinergic burden scales, or (ii) belonged to the same class as the drug identified in (i). The anticholinergic ADRs investigated were confusion, glaucoma, tachycardia, urinary retention, constipation, intestinal obstruction and mydriasis. RESULTS: Of the 101,365 cases reported in the FPVD, regarding the selected drugs, 9629 (9.5%) involved at least one anticholinergic ADR investigated. Patients who experienced at least one anticholinergic ADR had a median age of 61 years (interquartile range: 38-79), and the majority were women (58%). Confusion was the most frequently reported anticholinergic ADR (4603 cases, of which 81% were classified as serious), followed by tachycardia (n = 1541 cases, 70% serious), and urinary retention (1061 cases, 75% serious). It is noteworthy that 98% of the 561 reported cases of intestinal obstruction were classified as serious. The drug classes with the highest number of reports were (by far) anxiolytics, antidepressants, and antipsychotics. Some drugs linked to anticholinergic ADRs in the FPVD were not present in (or were assigned a low score by) commonly used anticholinergic scales, such as the Anticholinergic Cognitive Burden. CONCLUSIONS: Anticholinergic ADRs affect both older and younger adults. The existing scoring systems might not fully capture the range of medications involved in real-world anticholinergic-related events.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Pecquet PE, Moragny J, Gras V, et al. Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database. Drug Saf. 2026. PMID: 41528420. doi:10.1007/s40264-025-01643-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。